ABALXAmerican Funds American Balanced A
The schedule
- Fri30Oct
Q3 disclosure of portfolio holdings and asset allocation shifts ahead of year-end.
- Tue15Dec
Annual ex-dividend date for capital gains and income distributions, leading to a mechanical NAV reduction.
- Fri29Jan
Filing of the Q4 Annual Report, setting the stage for the new year's asset allocation strategy.
- Fri30Apr
First-quarter update on holdings and strategy adjustments.
Past
- Fri31Jul
Actual outcome: Bull · $41.14 at outcome
ABALX met earnings expectations exactly, reporting an EPS of $1.17. The release of the Semi-Annual N-CSR report detailed steady portfolio adjustments and solid performance metrics that reassured investors, driving a 1.8% rise in the fund's price and pushing it past the $40.85 bull target.
Release of the Semi-Annual N-CSR report detailing portfolio adjustments and performance metrics.
- Wed17Jun
Actual outcome: Bull · $40.78 at outcome
The Federal Reserve's interest rate decision and subsequent commentary provided a favorable macroeconomic backdrop, sparking a broad rally across both equities and fixed income. As a balanced fund, ABALX benefited directly from this market-wide appreciation, pushing its net asset value past the $40.25 bull target as investors digested the supportive monetary policy outlook.
Federal Reserve interest rate decision and market assimilation under the current economic regime.
- Thu30Apr
Actual outcome: Bull · $40.53 at outcome
The Q1 update did not show a negative surprise; it was a holdings and performance disclosure that confirmed the fund’s sector positioning and performance metrics rather than revealing any deterioration. With no miss, weak guidance, or adverse catalyst, the update was read as a constructive confirmation that the portfolio remained positioned well in a strong equity tape, which helped keep the shares at or near the bull target.
Release of the fund's Q1 sector allocations and performance metrics amid a heavily overbought equity tape.
